Dr. Yeh’s laboratory discovered Sentrin/SUMO that have revolutionized our understanding of cancer, heart disease, and neurodegenerative disorders. His laboratory also discovered the molecular basis of anthracycline-induced cardiotoxicity that shepherds in a new era of personalized cardio-protection for cancer patients undergoing chemotherapy. He received grants from the National Institute of Health, Department of Defense, and Cancer Prevention Research Institute of Texas. He was the McNair Scholar in the Texas Heart Institute, the Massachusetts General Hospital/Upjohn Scholar, Arthritis Investigator from the Arthritis Foundation, and the Established Investigator of the American Heart Association. Ed has mentored a large number of physician/scientists and basic scientists, who have become chair, dean, or independent investigators. He has written over 150 scientific papers, many of which are landmark contributions to science and medicine.

Dr. Yeh was elected to memberships in American Association of the Advancement of Science, the Association of American Physicians, American Society for Clinical Investigation, and Academia Sinica. He was honored as the Distinguished Alumnus of the University of California, Davis Medical School. He has held prominent positions as the President of the Houston Cardiology Society, President of the Board of American Heart Association, Houston Chapter, and board member of the American Heart Association, Texas and South-Central Affiliate.